RecruitingNot ApplicableNCT05367609

Personalized Perioperative Analgesia Platform (PPAP) for Pediatric Spine Fusion Surgery (sIRB)

Sponsor

Senthil Sadhasivam

Enrollment

300 participants

Start Date

Sep 20, 2022

Study Type

INTERVENTIONAL

Conditions

Spine Fusion PPAP

Summary

The purpose of this collaborative CTSA application is to develop an innovative perioperative precision analgesia platform (PPAP) to improve analgesia and reduce serious immediate and long-term adverse outcomes of perioperative opioids in children undergoing painful surgery.

Eligibility

Min Age: 10 YearsMax Age: 21 Years

Inclusion Criteria5

Children ages 10 to 21
ASA physical status 1 to 3
Undergoing Posterior-Lateral Spinal Fusion
Receives in-patient opioids
Prescribed opioids at discharge

Exclusion Criteria3

Serious illness
Preoperative severe pain
Preoperative opioid use or misuse

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTPreoperative Genotyping

Genotype based risk prediction and personalized pain management

Locations(3)

University of California

San Francisco, California, United States

Riley Children's Hospital

Indianapolis, Indiana, United States

UPMC Children's Hospital

Pittsburgh, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05367609

Related Trials

Post Marketing Study of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers Mixed With Autograft in Patients Undergoing Posterolateral Lumbar Fusion

NCT046798446 locations

MagnetOs Flex Matrix Compared to Trinity Elite Mixed With Local Autograft in Patients Undergoing up to Four-level Instrumented Posterolateral Fusion

NCT050379687 locations